Panfeng Tao,Jinqiao Sun,Zheming Wu,Shihao Wang,Jun Wang,Wanjin Li,Heling Pan,Renkui Bai,Jiahui Zhang,Ying Wang,Pui Y. Lee,Wenjing Ying,Qinhua Zhou,Jia Hou,Wenjie Wang,Bijun Sun,Mi Yang,Danru Liu,Ran Fang,Huan Han,Zhaohui Yang,Xin Huang,Haibo Li,Natalie Deuitch,Yuan Zhang,Dilan Dissanayake,Katrina Haude,Kirsty McWalter,Chelsea Roadhouse,Jennifer J. MacKenzie,Ronald M. Laxer,Ivona Aksentijevich,Xiaomin Yu,Xiaochuan Wang,Junying Yuan,Qing Zhou

Abstract:Activation of RIPK1 controls TNF-mediated apoptosis, necroptosis and inflammatory pathways<sup><a href="/articles/s41586-019-1830-y#ref-CR1">1</a></sup>. Cleavage of human and mouse RIPK1 after residues D324 and D325, respectively, by caspase-8 separates the RIPK1 kinase domain from the intermediate and death domains. The D325A mutation in mouse RIPK1 leads to embryonic lethality during mouse development<sup><a href="/articles/s41586-019-1830-y#ref-CR2">2</a>,<a href="/articles/s41586-019-1830-y#ref-CR3">3</a></sup>. However, the functional importance of blocking caspase-8-mediated cleavage of RIPK1 on RIPK1 activation in humans is unknown. Here we identify two families with variants in RIPK1 (D324V and D324H) that lead to distinct symptoms of recurrent fevers and lymphadenopathy in an autosomal-dominant manner. Impaired cleavage of RIPK1 D324 variants by caspase-8 sensitized patients' peripheral blood mononuclear cells to RIPK1 activation, apoptosis and necroptosis induced by TNF. The patients showed strong RIPK1-dependent activation of inflammatory signalling pathways and overproduction of inflammatory cytokines and chemokines compared with unaffected controls. Furthermore, we show that expression of the RIPK1 mutants D325V or D325H in mouse embryonic fibroblasts confers not only increased sensitivity to RIPK1 activation-mediated apoptosis and necroptosis, but also induction of pro-inflammatory cytokines such as IL-6 and TNF. By contrast, patient-derived fibroblasts showed reduced expression of RIPK1 and downregulated production of reactive oxygen species, resulting in resistance to necroptosis and ferroptosis. Together, these data suggest that human non-cleavable RIPK1 variants promote activation of RIPK1, and lead to an autoinflammatory disease characterized by hypersensitivity to apoptosis and necroptosis and increased inflammatory response in peripheral blood mononuclear cells, as well as a compensatory mechanism to protect against several pro-death stimuli in fibroblasts.

Linear Ubiquitination of RIPK1 on Lys612 Regulates Systemic Inflammation via Preventing Cell Death.

K63-linked Ubiquitination Regulates RIPK1 Kinase Activity to Prevent Cell Death During Embryogenesis and Inflammation

Tyrosine Phosphorylation Regulates RIPK1 Activity to Limit Cell Death and Inflammation.

[Research Progress on Receptor Interacting Proteins in Inflammation].

Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo.

The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation

Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis

Ubiquitination of RIP is Required for Tumor Necrosis Factor Α-Induced NF-κB Activation

RIPK1 Biallelic Activating Variants lead to Autoinflammatory Disease Driven by T cell Death

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling

Activation of Ikk by Tnf Alpha Requires Site-Specific Ubiquitination of Rip1 and Polyubiquitin Binding by Nemo

Regulation of Innate Immune Responses by Receptor Interacting Protein Kinases (172.43)

ABIN-1 Regulates RIPK1 Activation by Linking Met1 Ubiquitylation with Lys63 Deubiquitylation in TNF-RSC

A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1

IKKε and TBK1 prevent RIPK1 dependent and independent inflammation

TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members

Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway

TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation

RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis

25 years of research put RIPK1 in the clinic